The Journal of Bone and Joint Surgery (American). 2005;87:1810-1815.
doi:10.2106/JBJS.D.02830
© 2005 The Journal of Bone and Joint Surgery, Inc.
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow CME: Take the activities for this article:
CME 3: July, August, September 2005
Adult Hip Reconstruction Test 16: Fall 2005
Oncology Test 4: Spring 2006 (publication date May 15, 2006; expiration dat...
Right arrow [Supplementary Material]
Right arrow Letters to the Editor: Submit a response
Right arrow Letters to the Editor: View responses
Right arrow Alert me when this article is cited
Right arrow Alert me when Letters to the Editor are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schneiderbauer, M. M.
Right arrow Articles by Scully, S. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schneiderbauer, M. M.
Right arrow Articles by Scully, S. P.
Related Collections
Right arrow Adult Hip
Right arrow Oncology
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Facebook   Add to Technorati   Add to Twitter  
What's this?

Dislocation Rate After Hip Hemiarthroplasty in Patients with Tumor-Related Conditions

Michaela M. Schneiderbauer, MD1, Rafael J. Sierra, MD2, Cathy Schleck, BS2, William S. Harmsen, MS2 and Sean P. Scully, MD, PhD3

1 Department of Orthopedics, University Hospital of Basel, Spitalstrasse 21, 4031 Basel, Switzerland
2 Department of Orthopedic Surgery (R.J.S.) and Division of Biostatistics (C.S. and W.S.H.), Mayo Clinic, 200 First Street S.W., Rochester, MN 55905
3 Department of Orthopaedics/Rehabilitation, University of Miami, P.O. Box 01690601 (D-27), Miami, FL 33101. E-mail address: sscully{at}med.miami.edu

Investigation performed at the Mayo Clinic, Rochester, Minnesota

The authors did not receive grants or outside funding in support of their research or preparation of this manuscript. They did not receive payments or other benefits or a commitment or agreement to provide such benefits from a commercial entity. No commercial entity paid or directed, or agreed to pay or direct, any benefits to any research fund, foundation, educational institution, or other charitable or nonprofit organization with which the authors are affiliated or associated.


Background: Hemiarthroplasty is frequently used to treat femoral neck insufficiency resulting from neoplastic disease in the proximal part of the femur. The authors of a recent study analyzed the dislocation rates following hemiarthroplasty but excluded patients with tumor involvement of the site of the surgery as they hypothesized that the dislocation rates would be markedly higher in such patients. The current study was performed to compare the dislocation rate following hemiarthroplasties performed in patients without tumor involvement with the rate following hemiarthroplasties in patients with tumor involvement of the surgical site.

Methods: Patients who had undergone hemiarthroplasty following resection of a tumor involving the proximal part of the femur were identified in a total joint registry, and the patients' charts were reviewed retrospectively to determine dislocation rates, preoperative conditions, and postoperative outcomes and treatments. Between 1974 and 2001, 1812 patients were treated with hemiarthroplasty for reasons other than tumor involvement and 320 hemiarthroplasties were performed because of tumor-related conditions. The patients who were treated for a tumor-related condition were younger, and a higher proportion of them were men.

Results: The ten-year dislocation rate after the hemiarthroplasties performed for tumor-related conditions (10.9%) was higher than that following the hemiarthroplasties performed for non-tumor-related conditions (2.1%) (p = 0.002). The median time to dislocation in the patients with a tumor-related condition (twenty-four days) was shorter than that for the patients without tumor involvement (thirty-seven days). Preservation of the greater trochanter in patients with tumor involvement did not have a significant influence on the dislocation rate, but it showed a favorable trend toward decreasing that rate (hazard ratio = 3.5, p = 0.06).

Conclusions: The short-term and long-term dislocation rates associated with hemiarthroplasties performed for a tumor-related condition at the site of the surgery were significantly higher than those associated with hemiarthroplasties performed for reasons other than tumor involvement. Preservation of the greater trochanter showed a trend toward decreasing the likelihood of dislocation following the hemiarthroplasty, and it was more influential than the level of resection and the extent of soft-tissue compromise. We think that preservation of the greater trochanter should be attempted when it is justifiable according to the principles of oncologic surgery.

Level of Evidence: Prognostic Level II. See Instructions to Authors for a complete description of levels of evidence.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Facebook Facebook   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


Letters to the Editor:

Read all Letters to the Editor

Level of evidence
Dempsey S. Springfield, MD
JBJS Online, 30 Aug 2005 [Full text]
Untitled
James G. Wright, M.D., MPH, FRCSC
JBJS Online, 30 Aug 2005 [Full text]
Dislocation rate after hemiarthroplasty in patients with tumor-related conditions
Martin M. Malawer, et al.
JBJS Online, 4 Jan 2006 [Full text]
Dr. Scully, et al, respond to Dr. Malawer, et al
Sean P. Scully, M.D., Ph.D., et al.
JBJS Online, 18 Apr 2006 [Full text]